243 related articles for article (PubMed ID: 30190333)
1. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis.
Insua-Rodríguez J; Pein M; Hongu T; Meier J; Descot A; Lowy CM; De Braekeleer E; Sinn HP; Spaich S; Sütterlin M; Schneeweiss A; Oskarsson T
EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30190333
[TBL] [Abstract][Full Text] [Related]
2. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-κB in inflammatory breast cancer cells.
Gutsche K; Randi EB; Blank V; Fink D; Wenger RH; Leo C; Scholz CC
Free Radic Biol Med; 2016 Dec; 101():129-142. PubMed ID: 27717868
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival.
Afasizheva A; Devine A; Tillman H; Fung KL; Vieira WD; Blehm BH; Kotobuki Y; Busby B; Chen EI; Tanner K
BMC Cancer; 2016 Mar; 16():186. PubMed ID: 26944546
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix components in breast cancer progression and metastasis.
Oskarsson T
Breast; 2013 Aug; 22 Suppl 2():S66-72. PubMed ID: 24074795
[TBL] [Abstract][Full Text] [Related]
5. Tenascin C in metastasis: A view from the invasive front.
Lowy CM; Oskarsson T
Cell Adh Migr; 2015; 9(1-2):112-24. PubMed ID: 25738825
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.
Oskarsson T; Acharyya S; Zhang XH; Vanharanta S; Tavazoie SF; Morris PG; Downey RJ; Manova-Todorova K; Brogi E; Massagué J
Nat Med; 2011 Jun; 17(7):867-74. PubMed ID: 21706029
[TBL] [Abstract][Full Text] [Related]
8. The cJUN NH
Girnius N; Edwards YJ; Garlick DS; Davis RJ
Elife; 2018 Jun; 7():. PubMed ID: 29856313
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors.
Amin S; Kumar A; Nilchi L; Wright K; Kozlowski M
Mol Cancer Res; 2011 Aug; 9(8):1112-25. PubMed ID: 21719561
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
[TBL] [Abstract][Full Text] [Related]
11. TAK1-mediated stress signaling pathways are essential for TNF-alpha-promoted pulmonary metastasis of murine colon cancer cells.
Choo MK; Sakurai H; Koizumi K; Saiki I
Int J Cancer; 2006 Jun; 118(11):2758-64. PubMed ID: 16385569
[TBL] [Abstract][Full Text] [Related]
12. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
13. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
[TBL] [Abstract][Full Text] [Related]
14. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
15. Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.
Oudin MJ; Jonas O; Kosciuk T; Broye LC; Guido BC; Wyckoff J; Riquelme D; Lamar JM; Asokan SB; Whittaker C; Ma D; Langer R; Cima MJ; Wisinski KB; Hynes RO; Lauffenburger DA; Keely PJ; Bear JE; Gertler FB
Cancer Discov; 2016 May; 6(5):516-31. PubMed ID: 26811325
[TBL] [Abstract][Full Text] [Related]
16. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
17. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
19. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
[TBL] [Abstract][Full Text] [Related]
20. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
